Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display

13P - HPV integration status conversion and risk stratification by HPV integration levels in HPV integration-positive women: A 1-year follow-up

Date

20 Jun 2024

Session

Poster Display

Presenters

Fanwei Huang

Citation

Annals of Oncology (2024) 9 (suppl_5): 1-7. 10.1016/esmoop/esmoop103497

Authors

K. Li1, F. Huang2, T. Zhang3, F. Yang4, W. Duan4, S. Chen4, T. Hu5, X. Huang3

Author affiliations

  • 1 Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan/CN
  • 2 Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan/CN
  • 3 Tongji Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technology, Wuhan/CN
  • 4 New Technology Platform, Wuhan KDWS Biological Technology Co., Ltd, Wuhan/CN
  • 5 Tongji Hospital Affiliated Tongji Medical College of Huazhong, Wuhan/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 13P

Background

To evaluate the risk stratification by HPV-integration levels and HPV integration status conversion in HPV integration-positive women after 1-year follow-up.

Methods

This prospective cohort study conducted in Tongji hospital between June 2020 to August 2022 with 1297 consecutive HPV-positive women. The level of integration reads was stratified for risk assessment.

Results

A total of 194 women were HPV integration-positive and followed-up for at least 1 year. The immediate risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) increased from 36.2% (25/69) in women with 6-20 integration reads to 93.8% (30/32) in women with more than 1000 integration reads (Ptrend < 0.001). The 1-year cumulative risk of CIN2+ increased from 39.1% (27/64) in women with 6-20 integration reads to 96.9% (31/32) in women with more than 1000 integration reads (Ptrend < 0.001). The 1-year cumulative risk of CIN2+ with HPV integration reads more than 40 was 93.8% (90/96), which was significantly higher than that of HPV integration reads less than 40 (38/85, P < 0.001). At one-year follow-up, in women with HPV integration reads more than 40, 99.0% (95/96) of women progressed with positive outcomes (persistent integration at the same site, immediate CIN2+ and 1-year CIN2+). The progression rate of women with persistent integration at the same site was 41.6% (5/12), which was significantly higher than those of HPV-integration negative conversion (0/41, 0%, P < 0.001).

Conclusions

The number of HPV integration reads may have the potential in CIN2+ risk stratification to facilitate the clinical management of high-risk patients.

Legal entity responsible for the study

The authors.

Funding

The National Key R&D Program of China.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.